LONDON (AFX) - Ark Therapeutics Group PLC said it has raised 55 mln stg via
its initial public offering on the London Stock Exchange.
The shares being sold in the IPO have been priced at 133 pence per share,
giving the company a market capitalisation on listing of about 168 mln stg.
It said the offer generated a broad base of interest and was more than three
times over subscribed at the offer price.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's
Terms & Conditions